Hong Kong, China

Wanfei Li

This inventor holds 1 USPTO granted patent. Top assignee: Hong Kong Baptist University. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wanfei Li. Retrieved from https://idiyas.com/inventor/wanfei-li-0d4ovexj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wanfei Li: Innovator in Antiviral Research

Introduction

Wanfei Li is a prominent inventor based in Hong Kong, China. He has made significant contributions to the field of antiviral agents, particularly through his innovative research and development of patentiflorin A analogs.

Latest Patents

Wanfei Li holds 1 patent for his work titled "Patentiflorin A analogs as antiviral agents." This patent focuses on the development of analogs that are effective against various viral infections, including HIV, coronaviruses, Ebola, and influenza. The methods of use for these analogs highlight their potential in combating serious viral diseases.

Career Highlights

Li is affiliated with Hong Kong Baptist University, where he conducts his research. His work is characterized by a commitment to advancing antiviral therapies and improving public health outcomes.

Collaborations

Among his notable coworkers are Hongjie Zhang and Nga Yi Tsang, who contribute to the collaborative research environment at the university.

Conclusion

Wanfei Li's innovative work in antiviral research exemplifies the importance of scientific advancement in addressing global health challenges. His contributions are paving the way for new therapeutic options in the fight against viral infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…